News Related to Azathioprine

Related coverage linked through entity extraction aliases.

FcRn Inhibitors and Emerging Therapies Reshape Myasthenia Gravis Treatment Landscape

Apr 29, 2026

Three FcRn inhibitors are approved for generalized myasthenia gravis, with a head-to-head trial of efgartigimod and nipocalimab underway. Emerging therapies including telitacicept, gefurulimab, and CAR-T cell therapy (KYV-101) show promise, while Immunovant's batoclimab failed TED trials.

Neuromyelitis Optica Spectrum Disorder Pipeline Shows 10+ Active Therapies in Development

Mar 05, 2026

Over 10 companies are developing 12+ pipeline therapies for Neuromyelitis Optica Spectrum Disorder, including Roche's satralizumab Phase III pediatric trial and multiple anti-CD20 monoclonal antibody candidates.